Company Filing History:
Years Active: 2024
Title: Shih-Chi Wang: Innovator in Chimeric Influenza Vaccines
Introduction
Shih-Chi Wang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of virology, particularly in the development of chimeric influenza vaccines. With a total of three patents to his name, Wang's work is at the forefront of innovative vaccine research.
Latest Patents
Wang's latest patents focus on chimeric influenza virus hemagglutinin (HA) polypeptides. These polypeptides comprise one or more stem domain sequences, each exhibiting at least 60% homology with a stem domain consensus sequence of H1 subtype HA or H5 subtype HA. Additionally, they are fused with one or more globular head domain sequences, each also having at least 60% homology with a globular head domain consensus sequence of H1 subtype HA or H5 subtype HA. This innovative approach aims to enhance the efficacy of influenza vaccines.
Career Highlights
Shih-Chi Wang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on public health, particularly in combating influenza outbreaks. Wang's research is characterized by a commitment to advancing vaccine technology and improving global health outcomes.
Collaborations
Wang collaborates with notable colleagues, including Hsin-Yu Liao and Yi-An Ko. These partnerships enhance the research efforts and contribute to the development of effective vaccine solutions.
Conclusion
Shih-Chi Wang's contributions to the field of chimeric influenza vaccines exemplify the importance of innovation in public health. His work continues to pave the way for advancements in vaccine technology, ultimately benefiting society as a whole.